查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1452937

全球心律不整监测设备市场 2024-2031

Global Cardiac Arrhythmia Monitoring Devices Market 2024-2031
出版日期: | 出版商: Orion Market Research | 英文 225 Pages | 商品交期: 2-3个工作天内

价格

预计全球心律不整监测设备市场在预测期内将以 7.5% 的CAGR成长。全球心房颤动（AF）发病率和盛行率不断上升，推动了对心律不整监测设备的需求，从而推动了全球市场的成长。光是在美国，就有300 至600 万人患有房颤，预计到2050 年这一数字将达到约600 至1600 万。在欧洲，2010 年55 岁以上人群中房颤患病率约为900 万，预计将达到 2060 年，这一数字将达到 1400 万。据估计，到 2050 年，亚洲至少将有 7200 万人被诊断出房颤，其中约 300 万人患有房颤相关中风。老年族群罹患心房颤动的风险很高。根据世界卫生组织2021年10月报告，全球60岁及以上人口预计将从2020年的10亿增加到2050年的21亿，预计将对家居需求产生重大影响由于老年人更加依赖他人来满足他们的护理和其他需求，因此医疗保健软体市场变得更加重要。

不断增长的老年人口进一步满足了全球市场的需求。 2024 年 1 月，来自立陶宛两所大学的研究人员开发了一种病患安全监测技术，用于识别和管理引发心房颤动的个人因素。该技术是考纳斯理工大学生物医学工程研究所 (KTU BMEI) 和维尔纽斯大学 (VU) Santaros Clinics 合作的成果。心房颤动监测设备领域正在进行的研究进一步促进了市场的发展。便携式且易于监控的设备的开发预计将为全球市场的成长提供有利可图的机会。监控设备的高成本可能会限制其市场成长。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Abbott Laboratories
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • ACSDiagnostics
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • GE Healthcare
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Koninklijke Philips NV
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按设备类型分類的全球心律不整监测设备市场
    • 事件监控设备
    • 连续节律监测设备
    • 动态心电图监测设备
  • 按服务提供者分類的全球心律不整监测设备市场
    • 行动心臟遥测监测服务供应商
    • 独立诊断测试设施/诊所

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • AliveCor Inc.
  • Applied Cardiac Systems
  • Biotricity
  • Biotronik
  • BPL Medical Technologies
  • Fukuda Denshi Co. Ltd.
  • HD Medical Inc.
  • HemoCath Ltd.
  • iRhythm Technologies Inc.
  • Medi-Lynx Cardiac Monitoring LLC
  • Medtronic PLC
  • Moving Analytics Inc.
  • Nihon Kohden Corp.
  • Progetti SRL
  • SpaceLabs Healthcare (OSI Systems, Inc.)
  • Spacelabs Healthcare Inc.
  • Welch Allyn, Inc.
Product Code: OMR2028130

Global Cardiac Arrhythmia Monitoring Devices Market Size, Share & Trends Analysis Report by Device Type (Event Monitoring Devices, Continuous Rhythm Monitoring Devices, and Holter Monitoring Devices), and by Service Provider (Mobile Cardiac Telemetry Monitoring Service Providers, Independent Diagnostic Testing Facilities/Clinics) Forecast Period (2024-2031)

The global cardiac arrhythmia monitoring devices market is anticipated to grow at a considerable CAGR of 7.5% during the forecast period. The growing incidence and prevalence of atrial fibrillation (AF) globally has driven the demand for cardiac arrhythmia monitoring devices thereby driving the global market growth. In the US alone, 3 to 6 million people have AF, and the numbers are projected to reach approximately 6 to 16 million by 2050. In Europe, prevalent AF in 2010 was approximately 9 million among individuals older than 55 years and is expected to reach 14 million by 2060. It was estimated that by 2050 AF will be diagnosed at least in 72 million individuals in Asia, with approximately 3 million with AF-related strokes. The geriatric population is highly at risk of having AF. According to the October 2021 report of the World Health Organization, the global population of people aged 60 years and more is expected to increase from 1 billion in 2020 to 2.1 billion by 2050, which is expected to have a significant impact on the demand for home healthcare software market as older people are more dependent upon others for their care and other needs.

The growing geriatric population is further aiding to the demand for the global market. In January 2024, researchers from two Lithuanian universities have developed a patient-safe monitoring technology to identify and manage individual factors provoking atrial fibrillation. The technology is a result of a collaboration between Kaunas University of Technology Biomedical Engineering Institute (KTU BMEI) and Vilnius University (VU) Santaros Clinics. The ongoing researches in the field of AF monitoring devices are further aiding to the market development. The development of portable and easy to monitoring devices is anticipated to offer lucrative opportunities to the growth of the global market. The high cost of monitoring device may restrain their market growth.

Segmental Outlook

The global cardiac arrhythmia monitoring devices market is segmented based on device type, and service provider. Based on device type, the market is segmented into event monitoring devices, continuous rhythm monitoring devices, and Holter monitoring devices. Based on service providers, the market is segmented into mobile cardiac telemetry monitoring service providers, and independent diagnostic testing facilities/clinics.

Holter Monitoring Devices Anticipated to Exhibit Considerable Growth in the Global Cardiac Arrhythmia Monitoring Devices Market

The ability of these devices to be used for longer durations in diagnosing sporadic symptoms among patients is a key contributor to its growing market demand. They also offer faster and more convenient monitoring to increase patient compliance and enhance treatment outcomes. New product launches in this category are further aiding the growth of this market segment. For instance, in February 2021, RhythMedix launched a wearable cardiac monitor for arrhythmia detection. RhythMedix stated that the one-piece device is the first wearable multi-modality cardiac monitor offering Holter monitoring and connecting patients and clinicians for better patient care.

Regional Outlook

The global cardiac arrhythmia monitoring devices market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit considerable growth in the global market.

North America Held a Major Share in the Global Market

The regional market share is attributed to the high prevalence of arrhythmia and the availability of advanced healthcare infrastructure. Atrial fibrillation, often called AFib or AF, is the most common type of treated heart arrhythmia. According to the Centers for Disease Control & Prevention, in 2019, 183,321 mortalities occurred in the US due to AFib. It is estimated that 12.1 million people in the US will have AFib in 2030. The easy availability of advanced monitoring devices along with high healthcare expenditure is further contributing to the regional market share.

Market Players Outlook

The major companies serving the global cardiac arrhythmia monitoring devices market include Abbott Laboratories, Medtronic PLC, ACSDiangostics, GE Healthcare, and Koninklijke Philips NV among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and advancement in their product offerings to stay competitive in the market. For instance, in October 2023, Boston Scientific received FDA clearance and launched its next-generation insertable cardiac monitor for long-term monitoring of arrhythmias associated with atrial fibrillation, cryptogenic stroke, and syncope. The system (LUX-Dx II+) is designed with algorithms to detect and verify arrhythmias before sending an alert to clinicians and allows patient care teams to adjust event detection settings remotely and record symptoms without in-person visits, according to a company email sent to Healio.

The Report Covers:

  • Market value data analysis of 2023 and forecast to 2031.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global cardiac arrhythmia monitoring devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1.Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1.Research Methods and Tools
  • 1.2.Market Breakdown
    • 1.2.1.By Segments
    • 1.2.2.By Region

2.Market Overview and Insights

  • 2.1.Scope of the Report
  • 2.2.Analyst Insight & Current Market Trends
    • 2.2.1.Key Findings
    • 2.2.2.Recommendations
    • 2.2.3.Conclusion

3.Competitive Landscape

  • 3.1.Key Company Analysis
  • 3.2.Abbott Laboratories
    • 3.2.1.Overview
    • 3.2.2.Financial Analysis
    • 3.2.3.SWOT Analysis
    • 3.2.4.Recent Developments
  • 3.3.ACSDiagnostics
    • 3.3.1.Overview
    • 3.3.2.Financial Analysis
    • 3.3.3.SWOT Analysis
    • 3.3.4.Recent Developments
  • 3.4.GE Healthcare
    • 3.4.1.Overview
    • 3.4.2.Financial Analysis
    • 3.4.3.SWOT Analysis
    • 3.4.4.Recent Developments
  • 3.5.Koninklijke Philips NV
    • 3.5.1.Overview
    • 3.5.2.Financial Analysis
    • 3.5.3.SWOT Analysis
    • 3.5.4.Recent Developments
  • 3.6.Key Strategy Analysis

4.Market Segmentation

  • 4.1.Global Cardiac Arrhythmia Monitoring Devices Market by Device Type
    • 4.1.1.Event Monitoring Devices
    • 4.1.2.Continuous Rhythm Monitoring Devices
    • 4.1.3.Holter Monitoring Devices
  • 4.2.Global Cardiac Arrhythmia Monitoring Devices Market by Service Provider
    • 4.2.1.Mobile Cardiac Telemetry Monitoring Service Providers
    • 4.2.2.Independent Diagnostic Testing Facilities/Clinics

5.Regional Analysis

  • 5.1.North America
    • 5.1.1.United States
    • 5.1.2.Canada
  • 5.2.Europe
    • 5.2.1.UK
    • 5.2.2.Germany
    • 5.2.3.Italy
    • 5.2.4.Spain
    • 5.2.5.France
    • 5.2.6.Rest of Europe
  • 5.3.Asia-Pacific
    • 5.3.1.China
    • 5.3.2.India
    • 5.3.3.Japan
    • 5.3.4.South Korea
    • 5.3.5.Rest of Asia-Pacific
  • 5.4.Rest of the World

6.Company Profiles

  • 6.1.AliveCor Inc.
  • 6.2.Applied Cardiac Systems
  • 6.3.Biotricity
  • 6.4.Biotronik
  • 6.5.BPL Medical Technologies
  • 6.6.Fukuda Denshi Co. Ltd.
  • 6.7.HD Medical Inc.
  • 6.8.HemoCath Ltd.
  • 6.9.iRhythm Technologies Inc.
  • 6.10.Medi-Lynx Cardiac Monitoring LLC
  • 6.11.Medtronic PLC
  • 6.12.Moving Analytics Inc.
  • 6.13.Nihon Kohden Corp.
  • 6.14.Progetti SRL
  • 6.15.SpaceLabs Healthcare (OSI Systems, Inc.)
  • 6.16.Spacelabs Healthcare Inc.
  • 6.17.Welch Allyn, Inc.

LIST OF TABLES

  • 1.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
  • 2.GLOBAL EVENT MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 3.GLOBAL CONTINUOUS RHYTHM MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 4.GLOBAL HOLTER MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 5.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)
  • 6.GLOBAL MOBILE CARDIAC TELEMETRY MONITORING SERVICE PROVIDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 7.GLOBAL INDEPENDENT DIAGNOSTIC TESTING FACILITIES/CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 8.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 9.NORTH AMERICAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 10.NORTH AMERICAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
  • 11.NORTH AMERICAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)
  • 12.EUROPEAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 13. EUROPEAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
  • 14.EUROPEAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)
  • 15.ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 16.ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
  • 17.ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)
  • 18.REST OF THE WORLD CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 19.REST OF THE WORLD CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
  • 20.REST OF THE WORLD CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)

LIST OF FIGURES

  • 1.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023 VS 2031 (%)
  • 2.GLOBAL EVENT MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 3.GLOBAL CONTINUOUS RHYTHM MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 4.GLOBAL HOLTER MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 5.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023 VS 2031 (%)
  • 6.GLOBAL MOBILE CARDIAC TELEMETRY MONITORING SERVICE PROVIDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 7.GLOBAL INDEPENDENT DIAGNOSTIC TESTING FACILITIES/CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 8.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 9.US CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 10.CANADA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 11.UK CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 12.FRANCE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 13.GERMANY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 14.ITALY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 15.SPAIN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 16.REST OF EUROPE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 17.INDIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 18.CHINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 19.JAPAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 20.SOUTH KOREA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 21.REST OF ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 22.LATIN AMERICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 23.THE MIDDLE EAST AND AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)